CFC
IDXX icon

Coyle Financial Counsel’s Idexx Laboratories IDXX Stock Holding History

Coyle Financial Counsel’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$231K Buy
439
+52
+13% +$29.2K 0.04% 118
2026
Q1 		$217K Buy
387
+21
+6% +$13.5K 0.05% 106
2025
Q4 		$248K Buy
+366
New +$249K 0.05% 100

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Coyle Financial Counsel's IDXX Position: Q2 2026 in Review

Coyle Financial Counsel increased its Idexx Laboratories (IDXX) stake by 13% in Q2 2026, buying an estimated $29.2K and bringing the position to 439 shares worth $231K. The position accounts for 0.04% of the portfolio, ranked #118.

Coyle Financial Counsel first reported a position in IDXX in Q4 2025 and has held it in 3 quarters since. The position peaked at $248K in Q4 2025. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Coyle Financial Counsel held 439 shares of Idexx Laboratories worth $231K as of Q2 2026.
  • Coyle Financial Counsel bought 52 Idexx Laboratories shares in Q2 2026, an estimated $29.2K.
  • Idexx Laboratories made up 0.04% of Coyle Financial Counsel's portfolio in Q2 2026, its #118 holding.
  • Coyle Financial Counsel first reported a position in Idexx Laboratories in Q4 2025 and has held it in 3 quarters since.
  • Coyle Financial Counsel's Idexx Laboratories position peaked at $248K in Q4 2025.
  • 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Coyle Financial Counsel's 13F filing for Q2 2026, filed 7 Aug 2026.